Amesite Inc.: Form 10-Q/A for the period ended Sep 30, 2024
Filed with the SEC on Jan 2, 2025 and accepted by EDGAR at Jan 2, 2025, 22:20 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-07-01 to 2024-09-30 | $11.3k | us-gaap:Revenues |
| Research and development | 3 months2024-07-01 to 2024-09-30 | $139.7k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-07-01 to 2024-09-30 | −$927.3k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2024-07-01 to 2024-09-30 | −$908.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-07-01 to 2024-09-30 | −$0.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-07-01 to 2024-09-30 | −$0.34 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 3 months2024-07-01 to 2024-09-30 | −$488.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2024-09-30 | $1.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-09-30 | $2.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-09-30 | $3.2m | us-gaap:Assets |
| Current liabilities | At period end2024-09-30 | $843.0k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2024-09-30 | $2.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-25-000445. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.